170476 ⎘
Assays involving biological materials from specific organisms or of a specific nature from animals; from humans Assays involving receptors, cell surface antigens or cell surface determinants
Detection of membrane protein-therapeutic agent complexes by mass spectrometry
#902Method for screening an agent preventing or treating cancer using glycyl-tRNA synthetase and cadherin
#903Immunity to folate receptors
#904Stratification of pancreatic and ovarian cancer patients for susceptibility to therapy with PTK2 inhibitors
#905Method for detecting pancreatic cancer
#906Methods for treating and/or limiting development of diabetes
#907Compositions and methods for treatment
#908Methods and compositions for identifying minimal residual disease in acute lymphoblastic leukemia
#909Diagnostic assays and kits for detection of folate receptor 1
#910In vitro method for determining immunotoxicity of a compound
#911Diagnosis of malignant neoplasms using anti-Notch3 antibodies
#912Treating renal and liver dysfunction with TLR4 antagonists
#913Method and kits for determining platelet susceptibility to activation in a patient
#914Biomarkers for theranostics
#915Upregulation of rack-1 in melanoma and its use as a marker
#916In vitro method for diagnosing or predicting hypertension and/or early-stage cardiovascular end-organ damage by determining the concentration of soluble prorenin receptor
#917Identification and enrichment of cell subpopulations
#918Methods of identifying insect-TRPA1 modulators
#919Methods for Facilitating Diagnosis, Prognosis and Treatment of Cancer by Detecting HER1 Expression
#920Receptor binding ligands, their use in the detection of cells with biological interest
#921Companion diagnostic for anti-hyaluronan agent therapy and methods of use thereof
#922Methods and kits for measuring von Willebrand factor
#923Human gastrointestinal stem cell-derived primary intestinal epithelial cell system and methods of use thereof
#924Markers for acute kidney injury
#925Perlecan as a biomarker for renal dysfunction
#926Quantum dot-based optical sensors for rapid detection and quantitative analysis of biomolecules and biological materials
#927Ezrin assay method for the in vitro diagnosis of colorectal cancer
#928Receptor tyrosine kinase-like orphan receptor 1 (ROR1) single chain Fv antibody fragment conjugates and methods of use thereof
#929Antibodies that bind OV064 and methods of use therefor
#930CATALYST AND PROCESS FOR PREPARING ACROLEIN AND/OR ACRYLIC ACID BY DEHYDRATION REACTION OF GLYCERIN
#931AMPLIFYING RARE CELL SURFACE MARKERS
#932NUCLEIC ACID AMPLIFICATION WITH INTEGRATED MULTIPLEX DETECTION
#933IMMUNO-BASED BOTULINUM TOXIN SEROTYPE A ACTIVITY ASSAYS
#934Modulators of ATP-binding cassette transporters
#935Methods for Diagnosis, Prognosis and Methods of Treatment
#936Anti-CDH3 antibodies and uses thereof
#937Heteroaryl derivatives as CFTR modulators
#938Diagnostic and Prognostic Markers for Cancer
#939Extracellular and membrane-associated prostate cancer markers
#940Methods of screening T1R1/T1R3 heteromeric receptors for compounds that modulate umami taste signaling
#941EP1 INHIBITION
#942Prostate tumor markers and methods of use thereof
#943Sweet taste receptor-expressing construct, cell body expressing the same, and utilization thereof
#944Prevention of tissue ischemia and related compositions
#945Prevention of tissue ischemia and related methods
#946Dynamic monitoring of activation of receptor tyrosine kinase (RTK) in living cells using real-time microelectronic cell sensing technology
#947Method for Treating Arteriosclerosis
#948Methods and compositions for modulating hepsin activation of macrophage-stimulating protein
#949IMAGING AGENTS AND METHODS OF IMAGING NAALADASE OR PSMA
#950METHOD OF PREDICTING RISK OF PRE-TERM BIRTH
#951Systems and Methods for Detecting hENT1 Expression in Hematological Disorders
#952Treatment and prevention of dengue virus infections
#953METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF THYROID CANCER
#954Stratification of cancer patients for susceptibility to therapy with PTK2 inhibitors
#955Specific detection and quantification of phosphatidic acid using an trigalactosyldiacylglycerol-4 (TGD4) protein
#956Modulators of ATP-Binding Cassette Transporters
#957Compositions and methods for treatment of eye disorders
#958Immuno-based botulinum toxin serotype A activity assays
#959Anti-mesothelin antibodies and immunoconjugates
#960Sequences, antibodies, methods and kits for detection and in vitro assay of periostin, in order to provide a diagnosis, follow-up or prognosis of diseases and biological phenomena involving periostin
#961PODXL protein in colorectal cancer
#962COMPOSITIONS AND METHODS FOR DETECTING AND TREATING PROSTATE CARCINOMA
#963Detection of specific antigens in a population of antigens
#964Method of treating cancer with antibodies against long-form leukotriene B4 receptor BLT2
#965ENZYME FRAGMENT COMPLEMENTATION ASSAYS FOR MONITORING THE ACTIVATION OF THE VOLTAGE-GATED POTASSIUM ION CHANNEL HERG
#966Methods and kits for measuring von willebrand factor
#967Method Of Diagnosis Or Prognosis Of A Neoplasm Comprising Determining The Level Of Expression Of A Protein In Stromal Cells Adjacent To The Neoplasm
#968POLYMORPHISMS IN THE HUMAN GENE FOR THE MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN 1 (MRP-1) AND THEIR USE IN DIAGNOSTIC AND THERAPEUTIC APPLICATIONS
#969Method for treating inflammation by administering a compound which binds LDL-receptor-related protein (LRP) ligand binding domain
#970DIAGNOSIS AND TREATMENT OF NEUROECTODERMAL TUMORS
#971Method for Categorizing Circulating Tumor Cells
#972Elisa for a naturally-occurring soluble truncated form of IL-23 receptor
#973Anti-PRO87299 Antibodies
#974METHODS USING AXL AS A BIOMARKER OF EPITHELIAL-TO-MESENCHYMAL TRANSITION
#975DIAGNOSIS AND TREATMENT OF TUMORS
#976Genetically Modified Rat Models for Pain
#977Biomarker for psychiatric diseases including cognitive impairment and methods for detecting psychiatric diseases including cognitive impairment using the biomarkers
#978HUMAN CANCER-RELATED GENE, ITS ENCODED PRODUCTS AND APPLICATIONS
#979Anti-Notch3 antibodies
#980BIOLOGICAL MARKERS PREDICTIVE OF ANTI-CANCER RESPONSE TO EPIDERMAL GROWTH FACTOR RECEPTOR KINASE INHIBITORS
#981Cystic fibrosis transmembrane conductance regulator gene mutations
#982Anti-ILT7 antibody
#983TENEURIN C-TERMINAL ASSOCIATED PEPTIDES (TCAP) AND METHODS AND USES THEREOF
#984Anti-CDH3 antibodies labeled with radioisotope label and uses thereof
#985Human Aadenosine receptor crystals and uses thereof
#986Immuno-based botulinum toxin serotype A activity assays
#987METHODS FOR THE DIAGNOSIS OR PROGNOSIS OF COLORECTAL CANCER
#988Methods of modulating cold sensory perception via a cold- and menthol-sensitive receptor (CMR1)
#989E-cadherin as a biomarker of gastroesophageal reflux disease
#990Methods for using extracellular adenosine inhibitors and adenosine receptor inhibitors to enhance immune response and inflammation
#991Identification of DSG-3 as a biomarker for the detection of metastasis in lymph nodes
#992Methods for modulating neuronal responses
#993Serpentine transmembrane antigens expressed in human cancers and uses thereof
#994Modulators of cystic fibrosis transmembrane conductance regulator
#995Recombinant soluble truncated IL-23 receptor (IL-23R) capable of inhibiting IL-23R-mediated cell signaling
#996Methods And Marker Combinations For Screening For Predisposition To Lung Cancer
#997Method For Detecting And Purifying Pancreatic Beta Cells
#998PSCA: prostate stem cell antigen and uses thereof
#999Methods and systems for modulating hormones and related methods, agents and compositions
#1000Anti-human ROR1 antibodies
#1001Modulation of the Vps10p-domain receptor family for the treatment of mental and behavioural disorders
#1002CONNEXIN ENHANCES CHEMOTHERAPY-INCLUDED APOPTOSIS IN HUMAN CANCER CELLS INHIBITING TUMOR CELL PROLIFERATION
#1003USE OF 7-CHLORO-N,N,5-TRIMETHYL-4-OXO-3-PHENYL-3,5-DIHYDRO-4H-PYRIDAZINO[4,5-B] INDOLE-1-ACETAMIDE AS A BIOMARKER OF PERIPHERAL BENZODIAZEPINE RECEPTOR LEVELS
#1004Method of treating renal dysfunction based on perlecan as a biomarker
#1005Monoclonal antibody therapy for pancreas cancer
#1006Methods of administering lipocalins to treat metabolic disorders and cardiovascular diseases
#1007Diagnosis and treatment of breast cancer
#1008Methods and kits for measuring von Willebrand factor
#1009METHODS FOR APCDD1 MEDIATED REGULATION OF HAIR GROWTH AND PIGMENTATION AND MUTANTS THEREOF
#1010METHODS FOR PREDICTING AUTOIMMUNE DISEASE RISK
#1011System for screening agonists/antagonists of cellular signaling pathways
#1012Method, system and composition for optically inducing cardiomyocyte contraction
#1013METHODS OF ENHANCING TRANSLOCATION OF CHARGED ANALYTES THROUGH TRANSMEMBRANE PROTEIN PORES
#1014Tagged Ligands for Enrichment of Rare Analytes from a Mixed Sample
#1015Capturing particles
#1016DEVICES AND METHODS FOR ENRICHMENT AND ALTERATION OF CIRCULATING TUMOR CELLS AND OTHER PARTICLES
#1017Vaccinia virus protein A46 peptide and use thereof
#1018INHIBITION OF THE BETA3 SUBUNIT OF L-TYPE CA2+ CHANNELS
#1019Detection and treatment of non-dermal fibrosis
#1020Methods for diagnosis, prognosis and methods of treatment
#1021In vitro methods of detecting cells sensitive to sweet tastants by detecting expression of hetero-oligomeric T1R2/T1R3 taste receptors
#1022Markers for Assessing the Susceptibility of Cancer to IGF-1R Treatment
#1023Molecular marker for cancer stem cell
#1024Detection of human somatic cell reprogramming
#1025BIOLUMINESCENCE IMAGING-BASED SCREENING ASSAY AND INHIBITORS OF ABCG2
#1026SELECTIVE DIFFERENTIATION, IDENTIFICATION, AMD MODULATION OF HUMAN TH17 CELLS
#1027USING PHAGE EPITOPES TO PROFILE THE IMMUNE RESPONSE
#1028METHODS TO TREAT OR PREVENT A SKIN CONDITION USING A NELL1 PEPTIDE
#1029TIKI1 AND TIKI2, WNT INHIBITORS
#1030Teneurin and cancer
#1031TSPO-targeting compounds and uses thereof
#1032Cell lines expressing T1R2/T1R3 hetero-oligomeric taste receptors and assay system thereof for identification of taste compounds
#1033Methods of indentifying sweet taste modulators
#1034Methods of detecting T1R2- and T1R3-expressing cells potentially sensitive to sweet tastants
#1035Methods for predicting the response to anti-cancer treatment with an agonist of TLR7 or an agonist of TLR8
#1036Methods of treating cancer using the calcitonin-gene related peptide (“CGRP”) receptor antagonist CGRP8-37
#1037COMPOSITIONS AND METHODS FOR TREATING AND DIAGNOSING CANCER
#1038Monoclonal antibody therapy for pancreas cancer
#1039Compositions and methods for treatment
#1040Compositions and methods for treatment
#1041Targeting ABCB5 for cancer therapy
#1042SPECIFIC BINDING MEMBERS AGAINST SYNAPTOPHYSIN
#1043SOLUBLE CADHERIN 17 FOR THE DIAGNOSIS AND RISK STRATIFICATION OF CANCER AND TUMOR OF THE GASTROINTESTINAL TRACT
#1044MDA-7 PROTEINS AND METHODS OF USE THEREOF
#1045Mucosal membrane receptor and uses thereof
#1046Membrane transporter NaPi2b (SCL34A1) epitope for antibody therapy, antibodies directed thereto, and target for cancer therapy
#1047METHODS AND COMPOSITIONS FOR TREATING T-CELL LEUKEMIA
#1048Transporter assay
#1049Methods of Detecting Cells with a Disrupted Cell Membrane, Cells Infected with A Pathogen, Dying Cells or Dead Cells
#1050Compositions and methods affecting the signaling pathways of LRP receptors
#1051Methods for diagnosis, prognosis and methods of treatment
#1052GLP-1 receptor agonist bioassays
#1053CRYPTOTIS PARVA SCREENING MODEL FOR ANTIEMETIC POTENTIAL
#1054DIAGNOSIS, STAGING AND MONITORING OF INFLAMMATORY BOWEL DISEASE
#1055B7 family member zB7H6 and related compositions and methods
#1056METHOD OF ASSESSING MAMMALIAN EMBRYO QUALITY
#1057Modulators of ATP-binding cassette transporters
#1058Methods for Assessing CDK5 Activation and Function
#1059Modulators of ATP-binding cassette transporters
#1060ANTIBODY HAVING AN IMMUNE-ENHANCEMENT FUNCTION
#1061MFAP4 as a Marker For Regulatory Cells and Anti-Cancer Cells
#1062SMALL CELL LUNG CARCINOMA BIOMARKER PANEL
#1063Methods of identifying modulators of a cold-and-menthol-sensitive receptor (CMR1) and recombinant cells for use thereof
#1064Peripheral zone tumor cells, methods for their preparation and use
#1065Biomarker for the prediction of responsiveness to an anti-tumour necrosis factor alpha (TNF) treatment
#1066SCREENING METHODS FOR IDENTIFYING TARGET ANTIFUNGAL GENES AND COMPOUNDS BY DETECTING CELL SURFACE GLYCOPROTEINS
#1067Upregulation of rack-1 in melanoma and its use as a marker
#1068TRPC6 involved in glomerulonephritis
#1069INHIBITORS OF CALCIUM-ACTIVATED CHLORIDE CHANNELS
#1070Assays for non-apoptotic cell death and uses thereof
#1071Cystic fibrosis transmembrane conductance regulator gene mutations
#1072CHEMICAL SENSOR HAVING SENSITIVE FILM IMITATING OLFACTORY RECEPTOR
#1073Modulators of ATP-binding cassette transporters
#1074COMPOUNDS AND METHODS FOR THE DETECTION OF TRPV-6 CANCERS AND DRUG DELIVERY
#1075Marks as modifiers of the p53 pathway and methods of use
#1076Real-time analytical methods and systems
#1077SECRETION-RELATED BACTERIAL PROTEINS FOR NLRC4 STIMULATION
#1078Biomarkers of Hemorrhagic Shock
#1079Compositions and methods for diagnosing patients with acute atherosclerotic syndrome
#1080ALTERED N-CADHERIN PROCESSING IN TUMOR CELLS BY FURIN AND PROPROTEIN CONVERTASE 5A (PC5A)
#1081METHODS FOR DIAGNOSIS, PROGNOSIS AND METHODS OF TREATMENT
#1082Upregulation of RACK-1 in melanoma and its use as a marker
#1083COMPOSITIONS AND METHODS FOR MODULATING TLR14 ACTIVITY
#1084COMPOSITION AND METHOD FOR MEASURING THALLIUM INFLUX AND EFFLUX
#1085Human gastrointestinal stem cell-derived primary intestinal epithelial cell system and methods of use thereof
#1086N-CADHERIN: TARGET FOR CANCER DIAGNOSIS AND THERAPY
#1087Immunity to folate receptors
#1088METHOD FOR DETECTION OF A DISEASE-SPECIFIC COMBINATORIAL MOLECULAR PATTERN MOTIF IN A TISSUE SAMPLE OF A PATIENT'S SKIN
#1089Cell surface display, screening and production of proteins of interest
#1090Determination of 5-ASA efficacy in CRC prevention and/or treatment by gene expression analysis
#1091SCREENING METHODS
#1092Isothiazolopyridinones useful for the treatment of (inter alia) cystic fibrosis
#1093METHODS AND KITS FOR IDENTIFICATION OF ANTI-EXCITOTOXIC COMPOUNDS
#1094DEVICES AND METHODS FOR DIAGNOSING, PROGNOSING, OR THERANOSING A CONDITION BY ENRICHING RARE CELLS
#1095METHODS FOR DIAGNOSING, PROGNOSING, OR THERANOSING A CONDITION USING RARE CELLS
#1096Treatment of leukemias and chronic myeloproliferative diseases with antibodies to EphA3
#1097Neuromyelitis optica autoantibodies as a marker for neoplasia
#1098Use of soluble forms of the Desmoglein I protein for the purposes of screening for anti-ageing active agents
#1099DIAGNOSIS AND TREATMENT OF NEUROECTODERMAL TUMORS
#1100Methods for the delivery of toxins or enzymatically active portions thereof
#1101Immuno-based botulinum toxin serotype A activity assays
#1102IDENTIFICATION OF A PIN SPECIFIC GENE AND PROTEIN (PIN-1) USEFUL AS A DIAGNOSTIC TREATMENT FOR PROSTATE CANCER
#1103Therapies for cancer using RLIP76
#1104S100A9 interaction screening method
#1105Detection Assays and Use Thereof
#1106KLOTHO BETA
#1107METHOD OF DIAGNOSING AND TREATING ASTHMA
#1108FOLATE-CONJUGATES AND CORRESPONDING METAL-CHELATE COMPLEXES FOR USE IN DIAGNOSTIC IMAGING AND RADIOTHERAPY
#1109METHOD FOR IDENTIFICATION OF SOMATIC STEM CELLS
#1110Ezrin assay method for the in vitro diagnosis of colorectal cancer
#1111Gliomedin, Fragments Thereof and Methods of Using Same
#1112Optimized human T1R3 nucleic acid molecule
#1113Modulators of ATP-binding cassette transporters
#1114Optimized human T1R2 nucleic acid molecule
#1115ADAM-9 modulators
#1116Anti-Claudin 3 Monoclonal Antibody and Treatment and Diagnosis of Cancer Using the Same
#1117Compositions and methods of a phosphatidic acid binding protein
#1118STABILISATION OF BIOLOGICAL CELL MARKERS
#1119Compositions and methods for treating and diagnosing cancer
#1120Compositions and methods for treatment of eye disorders
#1121COMPOSITIONS AND METHODS FOR TREATMENT OF EYE DISORDERS
#1122Methods for treating neuromyelitis optica (NMO) by administration of eculizumab to an individual that is aquaporin-4 (AQP4)-IgG autoantibody positive
#1123Prevention of tissue ischemia, related methods and compositions
#1124Diagnosis and Treatment of Cancer Using Anti-Desmoglein-3 Antibodies
#1125Dual variable domain immunoglobulins and uses thereof
#1126Graded Expression of Snail as Marker of Cancer Development and DNA Damage-Based Diseases
#112718F-labelled folates
#1128Use of the 4-1BB receptor for identifying and/or separating activated regulatory Th cells (Treg)
#1129Diagnosis of carcinomas
#1130Promoter variants of the alpha-7 nicotinic acetylcholine receptor
#1131EPHA2 receptor antagonist antibodies
#1132Methods for diagnosing and monitoring liver diseases
#1133Procurement, Isolation, and Cryopreservation of Endometrial/Menstrual Cells
#1134Biomarkers for renal disease
#1135Method of quantifying membrane protein by mass spectrometry using peptide selection criteria
#1136Extracellular and membrane-associated prostate cancer markers
#1137RECEPTOR FOR AMYLOID BETA AND USES THEREOF
#1138DETECTION OF A BIOMARKER OF ABERRANT CELLS OF NEUROECTODERMAL ORIGIN IN A BODY FLUID
#1139B7-H1 AND SURVIVIN IN CANCER
#1140Method for diagnosing and treating Crohn's disease
#1141METHOD TO IDENTIFY AND TREAT SUBJECTS RESISTANT TO ACETYL SALICYLIC ACID
#1142Measurement methods
#1143DETECTION OF BACTERIAL PEPTIDOGLYCAN-LIKE COMPOUNDS
#1144Diagnostic kits to detect SP22 and SP22 antibodies
#1145Method of predicting metastasis of oral cavity cancer into cervical lymph node and diagnosis kit to be used in the prediction
#1146Methods of effecting Wnt signaling through Dkk structural analysis
#1147METHODS TO TREAT OR PREVENT HORMONE-RESISTANT PROSTATE CANCER USING siRNA SPECIFIC FOR PROTOCADHERIN-PC, OR OTHER INHIBITORS OF PROTOCADHERIN-PC EXPRESSION OR ACTIVITY
#1148TESTS TO PREDICT RESPONSIVENESS OF CANCER PATIENTS TO CHEMOTHERAPY TREATMENT OPTIONS
#1149Methods for Determining Notch Signaling and Uses Thereof
#1150Modulators of ATP-binding cassette transporters
#1151Methods of Diagnosing and Treating Complications of Pregnancy
#1152Compositions and methods for the modulation of PGRMC1
#1153Methods and Reagents for Preparing and Using Immunological Agents Specific for P-Glycoprotein
#1154Anti-ILT7 antibody
#1155Prion epitopes and methods of use thereof
#1156Use of A33 antigens and JAM-IT
#1157Monoclonal antibodies that specifically block biological activity of a tumor antigen
#1158Compositions and methods for the treatment of cancer
#1159Diagnostic Methods and Genetic Markers for Alzheimer Disease
#1160Cellular Pyrogen Test
#1161MDA-7 PROTEINS AND METHODS OF USE THEREOF
#1162Treatment and diagnosis of cancer
#1163Modulators of neuronal regeneration
#1164Modulators of ATP-binding cassette transporters
#1165Heteromeric taste receptors
#1166Heteromeric T1R2/T1R3 taste receptors
#1167Metadherin polypeptides, encoding nucleic acids and methods of use
#1168Methods of screening T1R1/T1R3 heteromeric receptors for compounds that modulate umami taste signaling
#1169Heteroaryl derivatives as CFTR modulators
#1170Cell lines that express hetero oligomeric taste receptors
#1171Methods of quantifying taste of compounds for food or beverages
#1172Methods of using T1R2/T1R3 heteromeric receptors to quantify taste of compounds for food or beverages
#1173Anti-zB7H6 antibody-drug conjugates
#1174IMMUNOGLOBULIN ASSOCIATED CELL-SURFACE DETERMINANTS IN THE TREATMENT OF B-CELL DISORDERS
#1175Methods of inhibiting T1R1/T1R3 heteromeric umami taste receptors
#1176Tagged ligands for enrichment of rare analytes from a mixed sample
#1177Vitro method for the prognosis of progression of a cancer and of the outcome in a patient and means for performing said method
#1178Methods of screening T1R2/T1R3 receptors for compounds which modulate sweet taste signaling
#1179HIGH-DENSITY ION TRANSPORT MEASUREMENT BIOCHIP DEVICES AND METHODS
#1180Method Of Evaluating Degree Of Skin Sensitivity Using Squamous Cell Carcinoma Antigen As An Indicator Thereof
#1181METHOD OF SCREENING USING c-MET, A NOVEL SUBSTRATE FOR GAMMA-SECRETASE
#1182Use of a T1R2 nucleic acid sequence to identify tastants
#1183NOVEL COMPOSITIONS AND METHODS FOR THE TREATMENT OF IMMUNE RELATED DISEASES
#1184Moesin, caveolin 1 and yes associated protein 1 as predictive markers of response to dasatinib in breast cancers
#1185Competitive receptor binding assay for detecting beta-glucans
#1186Method for treating vascular disorders
#1187Claudins as markers for early detection, diagnosis, prognosis and as targets of therapy for breast and metastatic brain or bone cancer
#1188Polymorphisms in the human gene for the multidrug resistance-associated protein 1 (MRP-1) and their use in diagnostic and therapeutic applications
#1189Methods and kits for measuring von Willebrand factor
#1190Indole derivatives as CFTR modulators
#1191Prostate cancer diagnosis and treatment
#1192Targeting ABCB5 for cancer therapy
#1193Imaging agents and methods of imaging NAALADase or PSMA
#1194Diagnosis of carcinomas
#1195PSCA: prostate stem cell antigen and distinguishing androgen receptor negative prostate cancer from benign prostatic hyperplasia
#1196Treatment of atherosclerosis
#1197Methods of Identifying and Treating Individuals Exhibiting MDR-1 Overexpression With Protein Tyrosine Kinase Inhibitors and Combinations Thereof
#1198UPREGULATION OF RACK-1 IN MELANOMA AND ITS USE AS A MARKER
#1199ANTI-PRO87299 ANTIBODIES
#1200METHOD TO IDENTIFY POLYPEPTIDE TOLL-LIKE RECEPTOR (TLR) LIGANDS